MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Harmony Biosciences Holdings, Inc. Common Stock

HRMY

#1797
Harmony Biosciences Holdings, Inc. Common Stock
28.5400
+0.25%
Sector:
Básica:
Profit Currency:
Rango diario
28.5400
28.5400
Rango anual
25.9020
40.8600
Cambio diario
+0.25%
Monthly Change
-24.24%
6 month change
-7.64%
Cambio anual
-7.64%
Cierres anteriores
28.4700
Open
28.5400
Bid
Ask
Low
28.5400
High
28.5400
Volumen
110
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. HRMY
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

Noticias

Zacks Zacks
BEAM CSTL HRMY
2026.02.25
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y
Zacks Zacks
IOVA CSTL HRMY
2026.02.25
IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress
Zacks Zacks
CSTL HRMY IMCR RXRX
2026.02.25
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Zacks Zacks
TEVA CORT CSTL HRMY
2026.02.25
Corcept's Q4 Earnings and Revenues Fall Short of Estimates
Zacks Zacks
RGEN CSTL HRMY IMCR
2026.02.25
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Zacks Zacks
APLS CSTL HRMY IMCR
2026.02.25
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
Investing Investing
HRMY
2026.02.25
UBS reduce precio objetivo de Harmony Biosciences por entrada anticipada de genérico
Investing Investing
HRMY
2026.02.25
UBS recorta el precio objetivo de Harmony Biosciences por entrada anticipada de genérico de Wakix
Investing Investing
HRMY
2026.02.25
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry
Investing Investing
HRMY
2026.02.24
Truist reitera mantener en acciones de Harmony Biosciences, fija objetivo de 25 dólares
Investing Investing
HRMY
2026.02.24
Truist reitera calificación Hold en Harmony Biosciences, fija objetivo de $25
Investing Investing
HRMY
2026.02.24
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd